Suchergebnisse - Cavazos, David

Modulation of Telomeres in Alternative Lengthening of Telomeres Type I Like Human Cells by the Expression of Werner Protein and Telomerase von Siddiqa, Aisha, Cavazos, David, Chavez, Jeffery, Long, Linda, Marciniak, Robert A.

Volltext Volltext Volltext

METB-09. METABOLIC ADAPTATION TO CHRONIC HYPOXIA IN GLIOBLASTOMA CELLS von Caflisch, Laura, Lodi, Alessia, Gruslova, Aleksandra, Cavazos, David, Garcia, Michael, Tiziani, Stefano, Brenner, Andrew

Volltext Volltext

miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer von Yu, Xiaojie, Zhang, Yiqiang, Cavazos, David, Ma, Xiuye, Zhao, Zhenze, Du, Liqin, Pertsemlidis, Alexander

Volltext Volltext Volltext

Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression von Bowers, Laura W, Cavazos, David A, Maximo, Ilane XF, Brenner, Andrew J, Hursting, Stephen D, deGraffenried, Linda A

Volltext Volltext Volltext

Obesity Promotes Aerobic Glycolysis in Prostate Cancer Cells von Cavazos, David A., deGraffenried, Matthew J., Apte, Shruti A., Bowers, Laura W., Whelan, Kaitlin A., deGraffenried, Linda A.

Volltext Volltext Volltext

MNGI-11. TREATMENT OF MENINGIOMA WITH TH-302 IN A PDX MOUSE MODEL AND CELL LINE von Patel, Vaibhav, Maknojia, Asif, Garcia, Michael, Cavazos, David, Gruslova, Aleksandra, Courtney, Bosse, Papanikolaou, Niko, Kidane, Dawit, Brenner, Andrew, Floyd, John

Volltext Volltext

DD-02 PHARMACODYNAMIC BIOMARKER ASSESSMENTS IN A PHASE I/II TRIAL OF THE HYPOXIA-ACTIVATED PRODRUG TH-302 AND BEVACIZUMAB IN BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA von Cavazos, David, Gruslova, Aleksandra, Sun, J., Floyd, John R., Fichtel, Lisa, Tadi, Surendar, Lodi, Alessia, Tiziani, Stefano, Hart, C.P., Eng, Clarence, Brenner, Andrew

Volltext Volltext

VB-111: A novel anti-vascular therapeutic for glioblastoma multiforme von Gruslova, Aleksandra, Cavazos, David A, Miller, Jessica R., Breitbart, Eyal, Cohen, Yael C, Bangio, Livnat, Yakov, Niva, Soundararajan, Anu, Floyd, John R., Brenner, Andrew J.

Volltext Volltext Volltext

Hypoxia-activated evofosfamide for treatment of recurrent bevacizumab-refractory glioblastoma: a phase I surgical study von Brenner, Andrew, Zuniga, Richard, Sun, Jessica D, Floyd, John, Hart, Charles P, Kroll, Stew, Fichtel, Lisa, Cavazos, David, Caflisch, Laura, Gruslova, Aleksandra, Huang, Shiliang, Liu, Yichu, Lodi, Alessia, Tiziani, Stefano

Volltext Volltext Volltext

Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma von Sareddy, Gangadhara R., Li, Xiaonan, Liu, Jinyou, Viswanadhapalli, Suryavathi, Garcia, Lauren, Gruslova, Aleksandra, Cavazos, David, Garcia, Mike, Strom, Anders M., Gustafsson, Jan-Ake, Tekmal, Rajeshwar Rao, Brenner, Andrew, Vadlamudi, Ratna K.

Volltext Volltext Volltext

5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells() von Henry, Sean, Kidner, Ria, Reisenauer, Mary R., Magedov, Igor V., Kiss, Robert, Mathieu, Véronique, Lefranc, Florence, Dasari, Ramesh, Evidente, Antonio, Yu, Xiaojie, Ma, Xiuye, Pertsemlidis, Alexander, Cencic, Regina, Pelletier, Jerry, Cavazos, David A., Brenner, Andrew J., Aksenov, Alexander V., Rogelj, Snezna, Kornienko, Alexander, Frolova, Liliya V.

Volltext Volltext Volltext

Activity of 2-Aryl-2-(3-indolyl)acetohydroxamates Against Drug-Resistant Cancer Cells von Aksenov, Alexander V., Smirnov, Alexander N., Magedov, Igor V., Reisenauer, Mary R., Aksenov, Nicolai A., Aksenova, Inna V., Pendleton, Alexander L., Nguyen, Gina, Johnston, Robert K., Rubin, Michael, De Carvalho, Annelise, Kiss, Robert, Mathieu, Véronique, Lefranc, Florence, Correa, Jaime, Cavazos, David A., Brenner, Andrew J., Bryan, Brad A., Rogelj, Snezna, Kornienko, Alexander, Frolova, Liliya V.

Volltext Volltext Volltext